Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4532 USD | -3.57% | -0.31% | +46.67% |
15/05 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
14/05 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
4.75Cr | - | - | - | |||
5.67TCr | - | |||||
4.1TCr | ||||||
3.81TCr | ||||||
2.69TCr | ||||||
2.56TCr |